Based on the spectrum of the anticancer activity of these AMPs, the cationic antimicrobial peptides (CAPs) can be divided into two broad classes [5]: the first includes peptides that are highly effective against bacteria and cancer cells, yet not against healthy mammalian cells; the second class includes peptides that are toxic to bacteria, cancer and non-cancerous cells. This evidence concerns the gene ADSL and cancer.